{"symbol": "MOR", "companyName": "MorphoSys AG", "exchange": "Nasdaq Global Select", "industry": "Biotechnology", "website": "http://www.morphosys.com", "description": "MorphoSys AG engages in the development of therapeutic antibodies to cure inflammatory and autoimmune diseases, as well as cancer and infectious diseases. The company operates through two business segments; Partnered Discovery and Proprietary Development.", "CEO": "", "issueType": "cs", "sector": "Healthcare", "tags": ["Healthcare", "Biotechnology"]}